切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Norepinephrine transporter - Angiotensin AT1 Receptors - Heparanases - Topoisomerases

22件产品中的 1-10

页面
每页
清除全部
  1. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    中文名: 羟喜树碱
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.8 mg/mL
      insoluble in H2O
  2. OGT 2115
    B7157 OGT 2115
    Target: Heparanases
    Summary: 乙酰肝素酶抑制剂
      insoluble in DMSO
  3. Ellipticine
    B7382 Ellipticine
    中文名: 玫瑰树碱,椭圆玫瑰树碱
    Target: Topoisomerases
    Summary: DNA拓扑异构酶II抑制剂
      ≥24.6 mg/mL
      insoluble in H2O
  4. Pirarubicin
    B2295 Pirarubicin
     1 Citation
    中文名: 吡柔比星
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,蒽环类抗生素
      ≥7.65 mg/mL
      insoluble in H2O
  5. Amitriptyline HCl
    B2231 Amitriptyline HCl
    中文名: 盐酸阿米替林
    Target: Trk Receptors|5-HT2 Receptors|Norepinephrine transporter|5-HT Transporters
    Summary: 血清素/去甲肾上腺素受体/5-HT4/5-HT2抑制剂
      ≥15.69 mg/mL
      ≥43.9 mg/mL
  6. Norfloxacin
    B1801 Norfloxacin
    中文名: 诺氟沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      insoluble in DMSO
      insoluble in H2O
  7. Valsartan
    B2214 Valsartan
    中文名: 缬沙坦
    Target: Angiotensin AT1 Receptors
    Summary: 血管紧张素II AT1受体拮抗剂
      ≥19.65 mg/mL
      insoluble in H2O
  8. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    中文名: 盐酸依立替康三水合物
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.1 mg/mL
      ≥2.5 mg/mL
  9. AVE 0991
    B1007 AVE 0991
     1 Citation
    Target: Angiotensin AT1 Receptors
    Summary: 血管紧张素-(1-7)受体激动剂
      ≥29.04 mg/mL
  10. Azilsartan
    B2210 Azilsartan
    中文名: 阿齐沙坦
    Target: Angiotensin AT1 Receptors
    Summary: 强效血管紧张素II 1型(AT1)受体反向激动剂
      ≥16.95 mg/mL
      insoluble in H2O

22件产品中的 1-10

页面
每页